In non-small cell lung cancer (NSCLC) cells, Erybraedin A inhibits cell adhesion to fibronectin via the inactivation of the protein tyrosine kinase Src and its interaction with β1 or β3 integrins, leading to cell death by anoïkis [28]. This evidence concerns the gene SRC and non-small cell lung carcinoma.